Source : TimesofIndia
In this case too death happened next day with bleeding from nose.
|Screenshot of TimesofIndia news. Click to zoom|
UPDATE: But despite infant deaths and two pending PILs (with yet another being heard in the Delhi High Court) against pentavalents, the Health Ministry announced on April 16 that pentavalents would be introduced in five more states - Gujarat, Haryana, Karnataka, Goa, Jammu and Kashmir and Puducherry in October.
In making the decision, the government overlooked the NTAGI, which has not even been convened since August 2010 when the body suggested limited introduction to Kerala and Tamil Nadu.
In short the ministry just decided to extend the Universal Immunization Programme (UIP) on April 17 !!!
UPDATE: On the first day of starting the programme in Kerala one 2 month old baby died following immunization. The post mortem report suggested death was due to a hypersensitivity reaction. The Human Rights Legal Network (HRLN) filed an affidavit in the Kerala High Court on behalf of the mother of this girl who died, asking for the programme to be stopped. The Kerala High Court ordered the Government to submit its report. In its counter-affidavit the Government admitted that 4 children died from adverse events following immunization (AEFI) with the new vaccine within about a month of its introduction. No other clear ‘alternate cause’ of death was found as defined by WHO Brighton classification. One of the babies was under weight and the other had a heart murmur but the Government affidavit does not say these were considered the cause of the children’s death
UPDATE : The Hindu Link on the story
UPDATE: News from Manorama Online says " A baby died the next day after taking the pentavalent vaccine. These were the symptoms
1. Bleeding from the nose.
2. Change in body color.
Death happened before reaching hospital.
KOCHI: A public interest writ petition was filed before the Kerala High Court against the administration of pentavalent vaccine on children in the State. The petition was filed by P.G. Hari, a homeopathy doctor from Wayanad and president of the Jankeeya Manushyavakasasamrakhana Prasthanam. The vaccinecombined DPT (diphtheria, pertussis, tetanus), Hepatitis B, and Hib (Hemophilus influenzae type B).
The petitioner claimed that adverse effects of the vaccine had been reported from countries such as Sri Lanka and Bangladesh. He contended that no study or research had been conducted before introducing the vaccine in the State.
The decision to roll out the vaccine in the State had been taken to appease vested interests such as the manufacturer of the vaccine and the national agencies such as the Global Alliance for Vaccines and Immunisation (GA-VI) and the Bill Gates foundation Trust.
In fact, the Bill Gates Foundation Trust had requested the Centre to introduce the vaccine in five States. But, the Centre had agreed to roll out the vaccine in only two States,Kerala and Tamil Nadu.
The petitioner said there was no need to include vaccination against Hepatitis B in the pentavalent vaccine as there had been no rise in the incidence of Hepatitis B infection in the country. Nor was it prevalent in the State as well.
It was the National Technical Advisory Group on Immunisation which had advised the Centre to roll out the vaccine in Tamil Nadu and Kerala. As per the decision, it would be introduced in the other States after reviewing the data about the result of the vaccination in Kerala and Tamil Nadu after one year.
Therefore, it could be assumed that it was a clinical trial. The trial was being undertaken without following the guidelines on clinical trials. A Division Bench on Wednesday directed the State government to produce a report of the Comptroller and Auditor General regarding the utilisation of the funds allotted for tsunami rehabilitation schemes.
Source: The Hindu Print Paper. Censored Online version here